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Brevetoxins are lipid-soluble, polyether,
marine toxins that have an excitatory action
on voltage-sensitive sodium channels (1).
Brevetoxins are produced by the marine
dinoflagellate Gymnodinium breve (2,3), an
organism responsible for toxic red tides in
the Gulf of Mexico (4). Nine brevetoxins
(PbTx1–9) are known to be produced by G.
breve, with PbTx-3, PbTx-1, and PbTx-2
being the predominate forms (5). PbTx-1 is
the most potent of the brevetoxins, with a
median lethal dose (LD50) of 180 µg/kg in
the mouse and 4 ng/mL in the ﬁsh (6). 
Brevetoxins bioaccumulate in various ﬁl-
ter-feeding organisms, particularly shellfish
(7). Shellﬁsh contaminated with brevetoxins
are toxic to humans and are responsible for
neurotoxic shellﬁsh poisoning (NSP). NSP is
characterized by gastrointestinal and neuro-
logic symptoms, which include tingling sen-
sations in the mouth and extremities, motor
incoordination, hot–cold flashes, slowed
pulse, pupil dilation, and mild diarrhea (8).
These symptoms may persist for several days.
G. breve red tides were ﬁrst documented
along the Gulf Coast of Florida in the 1530s,
and the first report of an associated marine
animal mortality event was published in 1844
(9). Fish are the primary organisms affected,
especially bottom-dwelling species; however,
larger fish and marine mammals are com-
monly susceptible during moderate and severe
red tides (10). The most common routes of
brevetoxin exposure in aquatic species is by
absorption of the toxin from lysed cells across
gill epithelium and direct ingestion of G.
breve and absorption of its toxins across gas-
trointestinal epithelia. Although finfish
account for most common animal mortalities
associated with red tide events, brevetoxin
accumulation in finfish has not been well
characterized. The adverse effects that have
been characterized in striped mullet (Mugil
cephalus) and mosquito ﬁsh (Gambusia afﬁnis)
include vigorous twisting and corkscrew
swimming, contractions, tail curvature, loss of
equilibrium, slow and irregular opercular
movements, quiescence, and sudden convolu-
tions leading to death (11,12).
Humans are also susceptible to adverse
effects from G. breve through direct inhala-
tion of brevetoxins and its absorption across
respiratory epithelia during red tide events.
G. breve cells are unarmored dinoflagellates
that lyse easily, releasing their toxins into the
water, which easily forms aerosols (13,14).
Reports of respiratory irritation occurred as
early as 1917 (15) and were later conﬁrmed
experimentally (16). Because of the fragile
nature of G. breve and the aerosolization of
its toxins as a result of wave action, breve-
toxin exposures can occur in areas of surf and
nearby beach areas. The effects have been
described as an abrupt irritant attack that
begins with paroxysmal coughing, accompa-
nied by tearing and rhinorrhea from irritated
eyes and nasal passages, all of which cease
promptly after leaving the beach areas (17). 
Given the multiple routes of exposure and
the frequency and duration of G. breve red
tides along the coastal areas of the Gulf of
Mexico, we decided to investigate the poten-
tial for adverse developmental effects of breve-
toxins. We chose to use a route of exposure
different from those described above, propos-
ing a route that presents a high risk to aquatic
species: maternal oocyte transfer (18). To
evaluate the hazard of maternal oocyte trans-
fer, we used microinjection to transfer known
amounts of toxin in an oil droplet into freshly
fertilized fish eggs. This method has previ-
ously been used to characterize the adverse
effects of ciguatoxin and chemical contami-
nants such as DDT (19,20). Both ciguatoxin
and DDT bioaccumulate in fish and are
found in the gonads; however, to date compa-
rable data has not been reported for breve-
toxin. We chose to investigate brevetoxin
because of the common occurrence and per-
sistence of red tides in the Gulf of Mexico and
their potential effects on resident and migra-
tory species that inhabit the estuaries to breed
and progress through early life phases (13).
PbTx-1 was chosen as the test compound,
because it is the most lipophillic of the breve-
toxins and hence has the greatest potential for
biomagniﬁcation.
Materials and Methods
Medaka fish (Oryzias latipes) (Carolina
Science and Math, Burlington, NC) were
maintained in a balanced salt solution (17.0
mM NaCl, 0.4 mM KCl, 0.2 CaCl2, 0.3
mM MgSO4, 0.24 mM NaHCO3), with a
14 hr light:10 hr dark cycle and a 25–28°C
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Brevetoxins are lipophilic polyether toxins produced by the red tide dinoﬂagellate Gymnodinium
breve, and their neurotoxic effects on adult animals have been documented. In this study, we
characterized adverse developmental effects of brevetoxin-1 (PbTx-1) using an exposure paradigm
that parallels the maternal oocyte transfer of toxin. Medaka ﬁsh (Oryzias latipes) embryos were
exposed to PbTx-1 via microinjection of toxin reconstituted in a triolein oil droplet. Embryos
microinjected with doses of 0.1–8.0 ng/egg (ppm) of brevetoxin-1 exhibited pronounced muscu-
lar activity (hyperkinesis) after embryonic day 4. Upon hatching, morphologic abnormalities were
commonly found in embryos at the following lowest adverse effect levels: 1.0–3.0 ppm, lateral
curvature of the spinal column; 3.1–3.4 ppm, herniation of brain meninges through defects in the
skull; and 3.4–4.0 ppm, malpositioned eye. Hatching abnormalities were also commonly
observed at brevetoxin doses of 2.0 ppm and higher with head-ﬁrst, as opposed to the normal tail-
first, hatching, and doses > 4.1 ng/egg produced embryos that developed but failed to hatch.
Given the similarity of developmental processes found between higher and lower vertebrates, ter-
atogenic effects of brevetoxins have the potential to occur among different phylogenetic classes.
The observation of developmental abnormalities after PbTx-1 exposure identiﬁes a new spectrum
of adverse effects that may be expected to occur following exposure to G. breve red tide events.
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mined optimal for breeding (21). Each 10-
gallon aquarium had four mature female and
two mature male fish. Fertilization occurs
externally, with the eggs attached to the
abdomen of the female. Eggs were collected
each morning from breeding females and
kept in embryo-rearing solution (133 mM
NaCl, 2.7 mM KCl, 2.1 mM CaCl2, 0.2
mM NaHCO3), where they were separated
and inspected for fertilization. Eggs were
placed in 2% agarose in 12.5% Hank’s solu-
tion (w/v) for stabilization during injection. 
Aluminosilicate micropipettes (O.D. 1
mm; Sutter Instrument Co., Navato, CA)
were pulled with a micropipette puller (P-87;
Sutter) and beveled using a micropipette
beveler (BV-10; Sutter). Individual micro-
pipettes were front loaded with either triolein
oil (95% pure; Sigma, St. Louis, MO) or
with PbTx-1 (Calbiochem, La Jolla, CA)
reconstituted into triolein oil. PbTx-1 was
concentrated into triolein oil by layering the
PbTx-1 (100 µg/mL in methanol) on top of
the triolein and evaporating the MeOH
under nitrogen to yield a ﬁnal concentration
of 3 µg/µL. Injections were made into the
yolk space with the aid of a gas pico-injector
system using an injection pressure of 7.8 psi
(PLI-100; Harvard Apparatus, Holliston,
MA). Balance pressure was maintained at
0.3 psi and increased to 3.2 psi before inser-
tion through egg chorion to compensate for
increased pressure within the egg. Eggs were
placed in 2% agarose prepared with 12.5%
Hank’s balanced salts before injection. Eggs
were injected 6–8 hr after fertilization, and
both vehicle-injected controls (the same
amount of methanol without PbTx-1 in tri-
olein oil) as well as noninjected controls
were performed along with the PbTx-1
injections. We injected 20–30 eggs per treat-
ment group. Injected droplet diameters were
measured via micrometer and the injected
volumes calculated. We calculated the con-
centration of PbTx-1 injected as the product
of the concentration of the toxin in the oil
droplet and the volume of the oil droplet.
After injections, the eggs were removed from
the stabilizing agarose and washed in 12.5%
Hank’s balanced salts for 1 min. Eggs were
then placed in 24-well plates containing 1.5
ml rearing solution and maintained in a 16
hr light: 8 hr dark cycle at 26°C. Embryos
were observed for development daily for 2
weeks with the aid of a stereomicroscope
(MZ12; Leica), and spinal hyperkinetic
events were recorded on embryonic day 4
over a 3-min time interval. Digital images
were captured with an autoexposure CCD
camera (MicroImage Video Systems Co.,
Boyertown, PA).
Results
PbTx-1 was administered to medaka eggs at
6 hr postfertilization by microinjection
(Figure 1). Larval survivability at embryonic
day 4 was 91% in noninjected animals and
90% of animals injected with triolein. A dose
of PbTx-1 caused a dose-dependent effect on
larval survivability, with a half maximal effect
at approximately 4.5 ng/egg (Figure 2).
Hatching of medaka normally occurred on
embryonic days 9–12 and occurred success-
fully in 79% of noninjected embryos and
75% of embryos injected with triolein. A
dose of PbTx-1 caused a dose-dependent
inhibition of hatching with a half maximal
effect at approximately 3 ng/egg (Figure 2). 
PbTx-1 also elicited a hyperkinetic activ-
ity, observed on embryonic day 4. This
hyperkinesis was manifested as tail and body
twitching and was monitored over a 3-min
interval. Fewer than ﬁve spinal hyperkinetic
twitches per 3 min were observed in both
the noninjected and triolein-injected vehicle
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Figure 1. Microinjection of medaka egg. (A) Uninjected egg 6 hr after fertilization. The droplets inside the
egg are the natural oil droplets that have coalesced. (B) Insertion of a microinjection tip into the egg and
the injection of a 2 nL droplet of triolein. 
Figure 2. Effects of PbTx-1 on larval survivability
and hatching. Fertilized eggs were microinjected
with eight dose ranges of brevetoxin-1. Larval
survivability was determined at embryonic day 4
and hatching at days 9–12. Twenty to 30 eggs
were injected with each dose.
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Figure 3. Effects of PbTx-1 on hyperkinesis. On embryonic day 4, fewer than five spinal hyperkinetic
twitches per embryo were monitored in both the noninjected and triolein-injected control groups over a 3-
min interval. Abbreviations: NI, noninjected; Veh, vehicle. Bars represent the mean ± SEM for > 5 embryos
in each dose range. 
*Mean response is signiﬁcantly different from the vehicle (p<0.05, Tukey multiple comparison test). 
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*control groups. A concentration-dependent
increase was observed for PbTx-1 in the fre-
quency of events. The lowest observable effect
occurred in the range of 0.1–0.9 ng/egg
(ppm), and a maximal effect of 50 twitches
over the 3-min time interval was observed at
the dosing range of 5.0–5.9 ng/egg (Figure 3).
Hyperkinesis declined at doses > 6.0 ng.
Increasing concentrations of 0.1–7.9
ng/egg PbTx-1 elicited several morphologic
effects on the embryos, some of which
affected hatching success. PbTx-1, given at
doses in the range of 0.1–3.0 ng/egg induced
a lateral curvature of the spinal column in
embryos, the severity of which was dependent
on the concentration of the dose. Figure 4A
shows an embryo hatched from an egg
injected with 1.1 ng PbTx-1, and Figure 4B
shows an embryo hatched from an egg
injected with 1.5 ng PbTx-1. Although this
degree of anatomical deformity did not inter-
fere with the hatching success of these
embryos, their swimming ability was greatly
impaired, leading to their inability to survive
longer than 10 days. Concentrations of PbTx-
1 between 1.5 and 3.0 ng/egg led to the
development of embryos with an even greater
degree of spinal curvature. In these cases, the
embryos seemed to no longer be able to hatch
out in the normal tail-first fashion, but
instead hatched out in an abnormal head-ﬁrst
fashion (Figure 5). Although these embryos
survived the hatching process, they too were
unable to survive due to their greatly impaired
swimming ability. Eggs that were injected
with > 4.0 ng PbTx-1 showed progressing
embryonic development but failed to hatch.
A more severe developmental effect of
PbTx-1 on medaka embryos was seen at
doses > 3.0 ng/egg. Eggs injected with doses
from 3.1–3.4 ng/egg of PbTx-1 produced
embryos that suffered from herniation of the
brain and meninges, possibly through skele-
tal defects in the skull (Figure 6). It is
unknown whether the cranial herniation was
due in part to the abnormal head-ﬁrst hatch-
ing of this embryo. However, eggs injected
with lower concentrations did not produce
embryos with similar defects, even though
the embryos had also hatched out head ﬁrst.
Eggs injected with 3.4–4.0 ng of PbTx-1 or
higher produced embryos that exhibited
malpositioned eyes, and an apparent lack of
a frontal skull (Figure 7). A summary of the
effects at the different doses is provided in
Table 1.
Discussion
The objective of this study was to quantify
the adverse developmental effects of PbTx-1
using an exposure paradigm that parallels the
maternal oocyte transfer of toxin. We have
previously used this paradigm to examine the
developmental effects of a related polyether
toxin, ciguatoxin. Through the use of
microinjection, we were able to determine
that the lowest observable adverse effect level
of PbTx-1 was 0.8–1.0 ng/egg, which is
equal to 0.8–1.0 ppm (wet weight embryo =
1.0 mg). With increasing toxin loads of
1.0–3.0 ng/egg, we saw a direct increase in
the incidence of lethal spinal defects and an
increase in the occurrence of abnormal hatch-
ing. Embryos exposed to 3.1–4.0 ng of
PbTx-1 exhibited deleterious morphologic
abnormalities such as herniation of the brain
and meninges and malpositioning of the eyes.
Embryos exposed to > 4.0 ng/egg exhibited
embryonic development, but failed to hatch.
Although we calculated the reported toxin
dosages administered at the time of injection,
we did not know the exact amounts absorbed
by the embryos. Injected oil droplets may
have different solubility properties from nat-
ural oil droplets. Microinjection of the toxin
directly into the natural oil droplet may
increase absorption efficiency. Accordingly,
PbTx-1 may have even more potent effects
than described in this report.
Red tide effects have been reported to
affect larval stages of ﬁnﬁsh. Riley et al. (22)
found that that the density of red drum lar-
vae (Scianops ocellatus) declined precipi-
tiously in the Aranasas Pass Channel (Port
Aransas, TX) after the September 1989 red
tide. These investigators also examined the
effects of G. breve on the hatching and larval
survivability of laboratory spawned red
drum. No effects on hatch rate were found
at cell concentrations up to 5,600 cells/mL;
Articles • Developmental toxicity of brevetoxin
Environmental Health Perspectives • VOLUME 109 | NUMBER 4 | April 2001 379
Figure 4. Developmental abnormalities (spinal curvature) after PbTx-1 egg microinjection. Embryos
hatched from eggs injected with (A) 1.1 ng PbTx-1 and (B) 1.5 ng PbTx-1. Both embryos exhibit a lateral
curvature of the spinal column, which is an effect commonly seen with brevetoxin injections. In (A), both
the natural (N) and injected (I) oil droplets are visible. 
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Figure 5. Developmental abnormalities (abnormal hatching) after PbTx-1 egg microinjection. (A) Embryo
normally hatching out tail-ﬁrst from an egg injected with 1.5 ng PbTx-1. (B) Embryo abnormally hatching
out head-ﬁrst from an egg injected with 2.2 ng PbTx-1. 
A Bhowever a cell concentration of 23 cells/mL
was lethal to larvae. These results indicate that
the larvae, but not the eggs, are susceptible to
G. breve. 
In contrast, an earlier study with the sea
urchin (Lytechinus variegatus) reported that
lysates of G. breve administered to eggs did
induce developmental abnormalities (23).
This study found that sperm motility, egg fer-
tilization, and development through the blas-
tula stage were unaffected; however, mortality
and developmental (axial) abnormalities
occurred in about 50% of the gastrula-stage
embryos and 80% of pluteus-stage embryos.
The reason for the difference between the
study with the red drum eggs and the sea
urchin eggs may result from the use of G.
breve cells and lysates.
The effect levels we report for brevetoxin
are about one-half to one-fifth the in vitro
inhibition constant (Ki) and median effective
dose (ED50) for binding and voltage-depen-
dent sodium channel-directed cytotoxicity
(24). The effect levels are also 1,000 times
lower than those we observe for the related
toxin ciguatoxin (CTX). CTX injected at 1–9
ppb into medaka eggs increased spinal hyper-
kinesis and produced induced spinal defects
(19). CTX is reported to be 20 times more
effective than brevetoxin as an ichthyotoxin
(0.5 nM vs. 10 nM for LD50) when adminis-
tered in the aquarium water (25). The higher
relative effect by microinjection may be due
to differences in the two routes of administra-
tion. An unexpected difference between the
developmental toxicity of both ciguatoxins
and brevetoxins was that PbTx-1, but not
CTX, caused cranial and optic deformities.
The reason for this difference has not been
elucidated, but it may be due to the biodistri-
bution of microinjected toxin or perhaps to
channel subtype speciﬁcity.
Red tides in the Gulf of Mexico are
dense concentrations of G. breve beginning
at 0.1 million cells/L and leading to discol-
oration at 2.0 million cells/L (13). Blooms
containing 0.2 million cells/L kill ﬁsh (26).
In culture G. breve produces approximately
10–15 pg of brevetoxin/cell (27). Thus, an
icthyotoxic bloom would contain approxi-
mately 5 nM brevetoxins. This value is close
to the 60-min LD50 for Poecilia reticulata for
PbTx-1 (4.0 ng/mL) in aquarium water (6).
Assuming a maximal tolerable concentration
of 5 nM (or approximately 5 ppm) for adult
fish, developmental effects such as the ones
described in this paper could be expected to
occur in animals having a bioaccumulation
and oocyte transfer factor of approximately
0.1. Brevetoxin accumulation in fish tissue
has not been reported; however, ciguatoxin
added to aquarium water has been deter-
mined to accumulate 9-fold in fish tissue
(24). Radioisotopic distribution studies for
brevetoxin have been conducted, but distrib-
ution to oocytes cannot be inferred from the
analysis of the gonads because these studies
were not conducted on sexually mature
female ﬁsh (28,29). However, oocyte transfer
factors of 0.1–1.0 have been reported for
organochlorines in salmon and lake trout
based on body burden measurements and are
generally related to egg lipid content (30). 
The observation of developmental
abnormalities in ﬁsh after PbTx-1 exposure
identifies a new spectrum of adverse effects
that may be expected to occur after exposure
to G. breve red tide events. Adverse effects
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Figure 6. Developmental abnormalities (meningeal herniation) following PbTx-1 egg microinjection. (A)
Embryo exhibiting herniation of the brain and meninges as it hatched from an egg that was injected with
3.1 ng PbTx-1; both the natural oil droplet (N) and the injected droplet (I) are visible. (B) is a magnified
view of the same embryo. 
A B
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Figure 7. Developmental abnormalities (malpositioned eyes) following PbTx-1 egg microinjection. (A)
Frontal and (B) lateral views of the same embryo, which hatched from an egg injected with 3.4 ng PbTx-1.
Injection of this concentration produced an embryo with malpositioned eyes, an apparent lack of a frontal
skull, and a great degree of spinal curvature in the tail.
AB
Table 1. Summary of adverse effects of brevetoxin-1 by dose.
Dose Characteristic adverse effect
Noninjected Hatched normally between days 9 and 12
Triolein Hatched normally between days 9 and 12
0.1–0.9 Hatched normally between days 9 and 12
1.0–1.9 Hatched normally, but delayed to days 10–15; spinal curvature present
2.0–2.9 Hatched abnormally head first with spinal curvature, delayed to days 10–15 or
HD; clumping of erythrocytes in vessels at day 4
3.0–3.9 Hatched abnormally head first; brain herniation/malpositioned eyes present;
hatching delayed to days 12–16 and usually HD; clumping of erythrocytes in vessels
4.0–4.9 Abnormally hatched dead (herniation); hatching delayed to days 12–16, or NH;
heart continued to pump up to day 18; clumping of erythrocytes in vessels
5.0–5.9 NH; heart continued to pump up to day 18; clumping of erythrocytes in vessels
6.0–6.9 NH; often failed to develop to later stages; clumping of erythrocytes in vessels
7.0–7.9 NH; often failed to develop to later stages; clumping of erythrocytes in vessels
Abbreviations: HD, hatched dead; NH, did not hatch. on larval life stages have been long suspected.
The persistence of red tides from the late fall
until early spring has suggested that the
spawning of some marine species may be
subject to the adverse effect of red tide tox-
ins. Steidinger et al. (10) also emphasized the
need for attention to the effects of red tide
outbreaks on migratory species, as many
species seek estuaries for breeding and nurs-
ery grounds. However, we also raise the
potential of lifetime accumulation of sub-
lethal body burdens of brevetoxins. Based on
studies with other classes of fat-soluble cont-
aminants, somatic stores of toxin in ﬁsh are
transferred during oogenesis and lead to lar-
val toxicity (30). This would be expected to
have a more pronounced effect on the first
brood; however, such effects may not neces-
sarily impact successful recruitment of fish
populations in successive years (31).
G. breve red tides have been associated
with mortality events of many aquatic ani-
mals including finfish, sea turtles, and sea
birds during their adult stages (4,9,10,
15,22,26,32–34). These animals have been
known to bioaccumulate substantial body
burdens of fat-soluble contaminants at times,
and in certain cases transfer toxicity to off-
spring during oogenesis. Mammals including
manatees, bottlenose dolphins, and humans
are affected by red tide toxins and also accu-
mulate substantial body burdens of fat-solu-
ble contaminants such as organochlorines. A
well-recognized means of contaminant trans-
fer in mammals is by lactation, with placental
transfer also being a potential risk (35). As
the developmental processes of both higher
and lower vertebrates is similar, the potential
exists for developmental toxicity and abnor-
malities to occur among different phyloge-
netic classes as a result of cumulative
exposure to G. breve red tide events. 
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